Literature DB >> 2144640

Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids.

J L Browning1, M P Ward, B P Wallner, R B Pepinsky.   

Abstract

Lipocortin-1 protein synthesis in resting monocytes is under the control of glucocorticoid steroids. This induction occurs at reasonable dexamethasone concentrations, may require concomitant synthesis of transcriptional factors, appears to be cell type specific, and has been observed only in primary tissues in our hands. Variability in the magnitude of the induction suggests that the regulation is complex, involving either additional factors or particular differentiation states. In addition to the induction of intracellular lipocortin-1, steroids cause the appearance of labelled lipocortin-1 on the outer surface of the cells. Whether cell breakage can account for this effect is unclear. Considerable microheterogeneity was found in preparations of recombinant-lipocortin-1. Aspects of N-terminal post-translational processing, N-terminal proteolysis, conformational states and the existence of an air-denatured form lacking alpha-helical structure contributed to this heterogeneity. We believe that these aspects are responsible for the variable biological potency of different preparations. It remains unclear whether this protein actually plays a physiological role in the regulation of the inflammatory response or achieves its effects through membrane binding and subsequent non-physiological perturbation of the cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144640

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  19 in total

Review 1.  Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1.

Authors:  J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

2.  Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression.

Authors:  S M Oliani; M J Paul-Clark; H C Christian; R J Flower; M Perretti
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1.

Authors:  M Perretti; A Ahluwalia; J G Harris; H J Harris; S K Wheller; R J Flower
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation.

Authors:  M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 5.  Lipocortin 1: glucocorticoids caught in the act?

Authors:  S F Smith
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

6.  Glucocorticoid deficiency increases phospholipase A2 activity in rats.

Authors:  B S Vishwanath; F J Frey; M J Bradbury; M F Dallman; B M Frey
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Dexamethasone induces an increase in intracellular and membrane-associated lipocortin-1 (annexin-1) in rat astrocyte primary cultures.

Authors:  J D McLeod; C Bolton
Journal:  Cell Mol Neurobiol       Date:  1995-04       Impact factor: 5.046

8.  Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo.

Authors:  S H Peers; F Smillie; A J Elderfield; R J Flower
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

9.  The local anti-inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1.

Authors:  G S Duncan; S H Peers; F Carey; R Forder; R J Flower
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

10.  Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat.

Authors:  C C Wu; J D Croxtall; M Perretti; C E Bryant; C Thiemermann; R J Flower; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.